From Estrogenic to Antiestrogenic Isoflavones: Implications for Hormone Dependent Breast Cancer

来源 :BIT`s 2nd Annual World Congress of Endobolism-2012(2012第二届内分 | 被引量 : 0次 | 上传用户:sd2009shandong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  PURPOSE: To determine the structural requirements for the transformation from estrogenic to anti-estrogenic compounds in a series of daidzein derivatives.DESIGN METHODS: A series of daidzein analogues were designed and synthesized.MCF-7 breast cancer cells were treated with the synthetic analogues to evaluate effect of daidzein and daidzein analogues on estrogen responsive element (ERE) transcriptional activity,ERα binding affinity, MCF-7 breast cancer cells colonial survival, PgR gene expression.In vivo studies of the anti-estrogenic effects of the most potent analogue on MCF-7 cell tumorigenesis were conducted using a xenografi mouse model.RESULTS: Daidzein analogues resulting from hydrogen substitution by isopropyl, isobutyl, cyclopentyl, and pyranogroup, were found to inhibit cell proliferation, estrogen-induced transcriptional activity, and ER regulated progesterone receptor gene expression.However, methyl and ethyl substitutions of the hydroxyl proton only led to moderate reduction of the estrogenic activities.Molecular modeling study of representative daidzein analogues using the crystal structure of ERα revealed that daidzein and the methyl substituted analogue fitted well in the ligand binding pocket of ERα in its estrogen bound configuration.The pyrano-substituted analogue was found to dock better in ERα in its antiestrogenbound configuration.CONCLUSION: These results demonstrated the structural requirements for the transformation of daidzein from an ER agonist to an antagonist.The most effective compound, 2 was found to reduce in vivo estrogen stimulated MCF7 cell tumorigenesis using a xenograft mouse model, and may serve as a novel antiestrogen for breast cancer treatment based on the structural motif of a natural isoflavone.
其他文献
1.Background: Automated identification and cytometric quantification of molecular markers (antibodies, histological stains, genetic probes) on the single cell level in tissue sections by means of slid
Introduction: Castration-resistant metastatic prostate cancer is a lethal disease for which no curative therapies exist.Despite improved understanding of many pathways and potential agents active in p
会议
Intensive research has been conducted towards developing more efficient and multifunctional drug delivery systems to deliver a therapeutic agent to a target site with amplified therapeutic value.Cance
会议
Epithelial-mesenchymal transition is the key process driving cancer metastasis.Oncogene/self renewal factor BMI-1 has been shown to induce EMT in cancer cells.Recent studies have implied that noncodin
会议
The present development of new therapies in oncology has been unlighted by the development of companion diagnostics.In general, 90% of drugs in the present therapeutic arsenal are only effective in 30
会议
Cigarette smoke is a major risk factor for bladder cancer and contributes to chemoresistance in bladder cancer patients who continue to smoke while receiving chemotherapy.Nicotine has been implicated
会议
Despite advances in chemotherapeutic regimens, the treatment of metastatic cancer remains a challenge.A key problem with chemotherapy drugs is nonspecific drug distribution, resulting in low tumour co
会议
In order to find one or more suppressors of tumor progression in vivo for head and neck squamous cell carcinoma (HNSCC), we searched for molecules down-regulated in HNSCC cells when the cells were tre
会议
CYP2D6 is the critical & prominent enzyme by which tamoxifen is metabolized to the active metabolite endoxifen.Recent literature suggests a minimal concentration threshold of 5.97 ng/mL of endoxifen i
会议
Neuroblastoma is an embryonic malignancy arising from neuroblasts.The mechanisms that regulate the origination of neuroblastoma are still not very clear.In this study, we revealed that 6-bromoindirubi
会议